{"gene":"GABPB1","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":1993,"finding":"GABPB1 (as part of NRF-2/GABP) was identified as a multi-subunit transcription factor whose beta subunit (GABPB1) forms heteromeric complexes with the DNA-binding alpha subunit and activates nuclear genes encoding mitochondrial respiratory chain components, including cytochrome c oxidase subunits IV and Vb. NRF-2 was shown to be identical to GABP, thus assigning a cellular role in respiratory gene expression to an ETS domain activator previously known only for viral promoter activation.","method":"Protein purification from HeLa cells, peptide sequencing, promoter binding assays, transfection assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — biochemical purification, peptide identity, functional promoter assays; foundational study replicated by subsequent work","pmids":["8383622"],"is_preprint":false},{"year":1993,"finding":"GABPB1 (E4TF1-53/E4TF1-47) was cloned and shown to contain four tandem ankyrin/notch repeats, lacks intrinsic DNA-binding activity, and heterodimerizes with the ETS-domain-containing alpha subunit (E4TF1-60/GABPα) to form a functional transcription factor complex; heterodimerization is essential for transcriptional activity.","method":"Protein purification, partial amino acid sequencing, cDNA cloning, gel retardation assay, recombinant protein expression in E. coli","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with purified recombinant proteins, functional gel-shift validation","pmids":["8441384"],"is_preprint":false},{"year":1995,"finding":"Four structurally distinct beta/gamma subunits of NRF-2 (including GABPB1/beta1 and beta2, and gamma1/gamma2 variants with a 12-amino-acid insertion) were cloned and shown to share a conserved ~70 amino acid transcriptional activation domain containing tandem glutamine-containing hydrophobic clusters. All four subunits associate with GABPα and support high-affinity binding to tandem NRF-2 sites, and all activate transcription equally when fused to a GAL4 DNA-binding domain.","method":"cDNA cloning, overexpression, co-immunoprecipitation, GAL4 fusion transcription assays, deletion mapping, PCR, RNase protection","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods in single study defining activation domain and subunit interactions","pmids":["7799916"],"is_preprint":false},{"year":1994,"finding":"The mouse genome encodes two highly related GABP beta polypeptides (GABPβ1 and GABPβ2) whose carboxy-terminal regions mediate dimerization via a coiled-coil (leucine zipper-like) mechanism. GABPβ1 and GABPβ2 can heterodimerize through this domain. The three GABP subunit genes map to three unlinked chromosomal loci yet show concordant expression patterns.","method":"Genomic and cDNA cloning, circular dichroism spectroscopy of synthetic peptides, leucine zipper swap experiment, chromosomal mapping","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — structural demonstration of coiled-coil dimerization by CD and functional leucine zipper replacement assay","pmids":["7958862"],"is_preprint":false},{"year":1996,"finding":"The transcriptional activation domain of NRF-2 (GABPB1) was mapped by deletion and alanine substitution mutagenesis to tandemly arranged clusters of hydrophobic amino acids (containing glutamines) within a ~40 residue region. Glutamine residues themselves are not required for activation; rather, the surrounding hydrophobic residues are essential. This mechanism is shared with NRF-1.","method":"Deletion mutagenesis, alanine substitution mutagenesis, transfection-based transcription assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis defining essential residues for activation domain function","pmids":["8816484"],"is_preprint":false},{"year":1998,"finding":"The crystal structure of GABPα/β (ETS domain – ankyrin repeat heterodimer) bound to DNA was determined at 2.15 Å resolution. The structure reveals: (1) the ankyrin repeats of GABPβ form an extensive protein-protein interface with both the ETS domain and a C-terminal extension of GABPα; (2) GABPα binds DNA through the GGA core recognition motif; (3) GABPβ is recruited by GABPα using both the ETS domain and a C-terminal extension of GABPα.","method":"X-ray crystallography at 2.15 Å resolution","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with functional context; landmark structural study","pmids":["9461436"],"is_preprint":false},{"year":2000,"finding":"The cellular coactivator C1/HCF directly interacts with GABPβ (GABPB1), functioning as a novel coactivator of GABP-mediated transcription. Mutations in GABPβ that reduce GABP transactivation potential also impair the C1-GABP interaction, indicating C1/HCF mediates GABP transcriptional activity. C1/HCF coordinates multi-protein enhancer assembly at HSV-1 IE gene promoters by interacting with GABP, Oct-1, and αTIF.","method":"Co-immunoprecipitation, mutagenesis, transcription assays, HSV-1 IE gene enhancer functional studies","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction demonstrated with mutagenesis linking binding to function","pmids":["10675337"],"is_preprint":false},{"year":2008,"finding":"PRC (PGC-1-related coactivator) associates with NRF-2/GABP in vivo via an HCF-1 intermediary. Neither PRC nor PGC-1α binds NRF-2β (GABPB1) directly; instead HCF-1 bridges the complex. Both PRC and NRF-2β bind HCF-1 in vitro. The PRC–HCF-1–NRF-2 complex occupies NRF-2-dependent promoters (TFB1M, TFB2M) in vivo, and PRC knockdown reduces TFB2M mRNA and mitochondrial transcripts and cytochrome oxidase activity.","method":"Co-immunoprecipitation, in vitro binding assays, chromatin immunoprecipitation, shRNA knockdown, enzyme activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Co-IP, ChIP, in vitro binding, functional KD) defining bridged complex","pmids":["18343819"],"is_preprint":false},{"year":2013,"finding":"GABP (requiring GABPB1 as a functional partner) directly binds the YAP/Yap promoter and activates YAP transcription. Depletion of GABP downregulates YAP, causing G1/S cell-cycle arrest and increased cell death, both rescued by YAP reconstitution. GABP transcriptional activity is inhibited by oxidative stress (glutathione depletion), linking GABP to the Hippo pathway as an upstream activator of YAP.","method":"ChIP, shRNA knockdown, YAP reconstitution rescue, cell cycle analysis, promoter reporter assay, in vivo mouse liver injury model","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrating direct promoter binding, genetic epistasis via YAP reconstitution rescue, multiple orthogonal methods","pmids":["23684612"],"is_preprint":false},{"year":2018,"finding":"GABPB1L (the long isoform of GABPB1, β1L), which enables GABP tetramer formation, is selectively required for activating the mutant TERT promoter in glioblastoma cells harboring TERT promoter mutations. Genetic disruption of β1L silences TERT expression in a TERT promoter mutation-dependent manner, leading to telomere shortening and cell death exclusively in mutant cells, with no effect on normal cells. In vivo, β1L disruption reduces tumor burden and extends survival in orthotopic xenograft models.","method":"CRISPR-mediated gene disruption, shRNA knockdown, TERT expression analysis, telomere length assays, orthotopic xenograft in vivo model","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 — CRISPR KO with isoform-specific rescue, in vivo validation, mutation-selective phenotype demonstrated across multiple models","pmids":["30205050"],"is_preprint":false},{"year":2022,"finding":"GABPB1 knockdown in thyroid cancer cells harboring TERT promoter mutations diminishes TERT expression and telomerase activity but paradoxically increases invasive potential in vitro and metastatic potential in a zebrafish xenograft model, with altered EMT marker expression. GABPB1 promoter hypermethylation suppresses its expression in aggressive thyroid cancers, and DNA methylation inhibitors restore GABPB1 expression. This demonstrates that GABPB1 has dual roles: required for TERT/telomerase activation but also functioning as a tumor suppressor to limit thyroid cancer progression.","method":"shRNA knockdown, invasion assays, zebrafish xenograft model, methylation-specific PCR, DNA methylation inhibitor treatment, EMT marker analysis","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 — multiple in vitro and in vivo methods but single lab; paradoxical tumor suppressor finding adds complexity","pmids":["35326537"],"is_preprint":false},{"year":2022,"finding":"GABPB1 silencing in TERT-promoter-mutant GBM cells reduces lactate, glutathione (GSH), and hyperpolarized [1-13C]lactate production as detected by 1H- and 13C-MRS. Mechanistically, GSH reduction is linked to reduced pentose phosphate pathway flux and glucose-6-phosphate dehydrogenase activity, and lactate reduction is associated with decreased glycolytic flux, NADH, and reduced expression/activity of GLUT1, monocarboxylate transporters, and lactate dehydrogenase A.","method":"1H-MRS, hyperpolarized 13C-MRS, enzyme activity assays, shRNA knockdown, in vivo tumor models","journal":"Neuro-oncology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple metabolic readouts in vitro and in vivo, single lab","pmids":["35460557"],"is_preprint":false},{"year":2023,"finding":"HOMER3 and platelet-activating factor acetylhydrolase 1b catalytic subunit 3 cooperate to upregulate GABPB1 protein levels in NSCLC, which in turn controls mitochondrial inner membrane gene expression and mitochondrial function. Loss of HOMER3 reduces GABPB1 levels, leading to mitochondrial dysfunction and decreased proliferation and invasion of lung cancer cells in vitro and in vivo.","method":"shRNA knockdown, co-immunoprecipitation, in vitro and in vivo proliferation/invasion assays, mitochondrial function assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2-3 — upstream regulation of GABPB1 established by KD and Co-IP; single lab","pmids":["38081871"],"is_preprint":false},{"year":2023,"finding":"GABPB1 was identified as a developmentally essential gene in mice; CRISPR/Cas9 knockout of Gabpb1 results in early preimplantation developmental arrest associated with apoptosis. In nuclear transfer (cloned) embryos, Gabpb1 fails to be properly reactivated due to H3K9me3-mediated repression (partly through repressed Klf16 expression), and supplementation of Gabpb1 mRNA supports efficient preimplantation development of cloned embryos.","method":"CRISPR/Cas9 knockout, siRNA screening, mRNA supplementation rescue, H3K9me3 ChIP analysis, embryo development assays","journal":"Life science alliance","confidence":"Medium","confidence_rationale":"Tier 2 — KO lethal phenotype with mRNA rescue, epigenetic mechanism identified; single lab","pmids":["37640449"],"is_preprint":false},{"year":2019,"finding":"Erastin upregulates the lncRNA GABPB1-AS1, which blocks translation of GABPB1 protein (without altering mRNA levels), leading to reduced PRDX5 (Peroxiredoxin-5) expression, suppressed antioxidant capacity, and ferroptotic cell death in HepG2 hepatocellular carcinoma cells. GABPB1 protein thus functions downstream of GABPB1-AS1 to maintain PRDX5 expression and cellular redox homeostasis.","method":"Erastin treatment, lncRNA overexpression/knockdown, Western blot (protein level without mRNA change), PRDX5 reporter assay, cell viability assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — translational repression mechanism with functional link to PRDX5 and ferroptosis; single lab","pmids":["31700067"],"is_preprint":false},{"year":2024,"finding":"BAIAP2L2 interacts with GABPB1 protein to inhibit its ubiquitin-mediated degradation and promote its nuclear translocation in hepatocellular carcinoma cells. NFκB1 stimulates BAIAP2L2 transcription by binding its promoter. Through stabilizing GABPB1 and promoting its nuclear entry, BAIAP2L2 reduces ROS levels and enhances HCC malignancy and lenvatinib resistance.","method":"Co-immunoprecipitation, ubiquitination assay, nuclear/cytoplasmic fractionation, promoter binding ChIP assay, shRNA knockdown, ROS measurement","journal":"Cancer gene therapy","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP demonstrates interaction, ubiquitination assay shows degradation mechanism, fractionation shows localization; single lab","pmids":["39496939"],"is_preprint":false},{"year":2024,"finding":"shRNA-mediated suppression of GABPB1 in NSCLC cell lines A549 and H1299 decreases cell growth, clone formation, and increases apoptosis rate, confirming a cancer-promoting role for GABPB1 in lung cancer cell proliferation and survival.","method":"shRNA knockdown, colony formation assay, CCK-8 cell viability, apoptosis assay","journal":"Discover oncology","confidence":"Low","confidence_rationale":"Tier 3 — single lab, KD phenotype without detailed pathway placement","pmids":["38466508"],"is_preprint":false}],"current_model":"GABPB1 encodes the beta subunit(s) of the heteromeric ETS transcription factor GABP/NRF-2; it contains ankyrin repeats that mediate direct protein-protein contact with the DNA-binding GABPα subunit (as revealed by crystal structure), a C-terminal coiled-coil domain enabling GABPβ homodimerization and tetramerization, and a conserved hydrophobic activation domain; the tetramer-forming long isoform GABPβ1L selectively activates mutant TERT promoters in cancer cells, while GABPB1 broadly activates nuclear-encoded mitochondrial respiratory and biogenesis genes through complexes that include HCF-1 and PRC coactivators, regulates YAP transcription as part of the Hippo pathway, is itself regulated post-translationally by BAIAP2L2-dependent protection from ubiquitin-mediated degradation, and is required for preimplantation mouse development where its loss causes apoptosis."},"narrative":{"teleology":[{"year":1993,"claim":"Identification of GABPB1 as the non-DNA-binding subunit of GABP/NRF-2 resolved how an ETS-family factor activates nuclear-encoded mitochondrial respiratory genes, establishing the obligate α/β heterodimer architecture.","evidence":"Protein purification from HeLa cells with peptide sequencing, promoter binding and transfection assays; independent cDNA cloning showing ankyrin repeats and heterodimerization requirement","pmids":["8383622","8441384"],"confidence":"High","gaps":["No structural detail on how ankyrin repeats contact GABPα","Activation domain not yet mapped"]},{"year":1995,"claim":"Characterization of multiple GABPB splice isoforms and mapping of a conserved hydrophobic activation domain defined the modular architecture through which GABPB1 transduces transcriptional activation, while identification of the coiled-coil dimerization motif explained how β subunits oligomerize.","evidence":"cDNA cloning, GAL4 fusion assays, deletion/alanine mutagenesis, circular dichroism spectroscopy of coiled-coil peptides","pmids":["7799916","7958862","8816484"],"confidence":"High","gaps":["No high-resolution structure of the coiled-coil tetramer","Functional distinction between β1 and β2 isoforms unclear"]},{"year":1998,"claim":"The 2.15 Å crystal structure of the GABPα ETS domain–GABPβ ankyrin repeat complex on DNA revealed the molecular basis for obligate heterodimerization and indirect DNA recognition by the β subunit.","evidence":"X-ray crystallography at 2.15 Å resolution","pmids":["9461436"],"confidence":"High","gaps":["Structure lacks the activation domain and coiled-coil tetramerization region","No structure of the full-length tetramer on tandem ETS sites"]},{"year":2000,"claim":"Discovery that HCF-1 (C1) directly binds GABPB1 and functions as a coactivator established the first known coactivator partnership for GABP, later shown to bridge additional coactivators such as PRC to NRF-2-dependent promoters.","evidence":"Co-immunoprecipitation, mutagenesis linking interaction to transactivation, in vitro binding, ChIP, shRNA knockdown of PRC","pmids":["10675337","18343819"],"confidence":"High","gaps":["Stoichiometry of the PRC–HCF-1–GABP complex on chromatin unknown","Whether other coactivators use the same HCF-1 bridge is untested"]},{"year":2013,"claim":"Demonstration that GABP directly binds and activates the YAP promoter linked GABPB1 to Hippo pathway regulation and cell-cycle control, broadening its role beyond mitochondrial biogenesis.","evidence":"ChIP, shRNA knockdown, YAP reconstitution rescue, cell-cycle analysis, in vivo mouse liver injury model","pmids":["23684612"],"confidence":"High","gaps":["Whether GABP regulation of YAP is tissue-specific is unexplored","Mechanism by which oxidative stress inhibits GABP DNA-binding activity not fully resolved"]},{"year":2018,"claim":"The finding that the tetramer-forming long isoform GABPB1L is selectively required for mutant TERT promoter activation in glioblastoma provided an isoform-specific oncogenic mechanism and a potential therapeutic vulnerability.","evidence":"CRISPR disruption of GABPB1L, isoform-specific rescue, telomere length assays, orthotopic xenograft models","pmids":["30205050"],"confidence":"High","gaps":["Whether GABPB1L selectivity for mutant TERT extends to all TERT-promoter-mutant cancer types is incompletely tested","Structural basis for why the tetramer, but not the dimer, activates the mutant promoter is unknown"]},{"year":2019,"claim":"Identification of lncRNA GABPB1-AS1 as a translational repressor of GABPB1 revealed a post-transcriptional regulatory layer linking GABPB1 levels to antioxidant defense (PRDX5 expression) and ferroptosis susceptibility.","evidence":"Erastin treatment, antisense lncRNA overexpression/knockdown, Western blot showing protein but not mRNA change, PRDX5 reporter assay in HepG2 cells","pmids":["31700067"],"confidence":"Medium","gaps":["Translational repression mechanism (ribosome stalling vs. mRNA sequestration) is undefined","Generalizability beyond HepG2 cells not established"]},{"year":2022,"claim":"Studies in thyroid cancer and GBM revealed that GABPB1 silencing not only reduces TERT expression but also reshapes glycolytic/redox metabolism and paradoxically enhances invasion in certain contexts, revealing context-dependent roles.","evidence":"shRNA knockdown, 1H/13C-MRS metabolomics, invasion assays, zebrafish xenograft, methylation-specific PCR","pmids":["35326537","35460557"],"confidence":"Medium","gaps":["Whether metabolic changes are direct transcriptional targets or secondary to TERT loss is unresolved","Paradoxical tumor-suppressive effect in thyroid cancer awaits independent replication"]},{"year":2023,"claim":"Gabpb1 knockout causes preimplantation embryonic lethality with apoptosis in mice, and mRNA supplementation rescues cloned embryo development, establishing GABPB1 as essential for early mammalian development.","evidence":"CRISPR/Cas9 knockout, mRNA rescue, H3K9me3 ChIP in nuclear transfer embryos","pmids":["37640449"],"confidence":"Medium","gaps":["Specific GABPB1 target genes required for preimplantation survival are not identified","Whether the essential role maps to mitochondrial gene regulation or another program is unknown"]},{"year":2024,"claim":"BAIAP2L2 was shown to stabilize GABPB1 by blocking ubiquitin-mediated degradation and promoting nuclear translocation, identifying the first post-translational stabilization pathway for GABPB1 and linking it to drug resistance in HCC.","evidence":"Co-immunoprecipitation, ubiquitination assay, nuclear/cytoplasmic fractionation, ChIP for NFκB1 binding to BAIAP2L2 promoter","pmids":["39496939"],"confidence":"Medium","gaps":["The E3 ubiquitin ligase targeting GABPB1 for degradation is unidentified","Whether BAIAP2L2-mediated stabilization operates outside HCC is untested"]},{"year":null,"claim":"Major open questions include the structural basis for GABPB1L tetramer selectivity at mutant TERT promoters, the identity of the E3 ligase governing GABPB1 turnover, and the full set of direct transcriptional targets that account for GABPB1's essential developmental role.","evidence":"","pmids":[],"confidence":"High","gaps":["No full-length tetramer structure exists","E3 ligase for GABPB1 ubiquitination unknown","Genome-wide direct target catalog in developmental context is lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,2,4,8,9]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,5,7]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,8,15]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2,4,8,9]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,7,12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[9,10,11]}],"complexes":["GABP (NRF-2) heterodimer/tetramer","PRC–HCF-1–NRF-2 coactivator complex"],"partners":["GABPA","HCF1","PPRC1","BAIAP2L2","HOMER3"],"other_free_text":[]},"mechanistic_narrative":"GABPB1 encodes the transcriptional activation subunit of the heteromeric ETS-family transcription factor GA-binding protein (GABP/NRF-2), functioning as an obligate partner of the DNA-binding GABPα subunit to regulate nuclear-encoded mitochondrial genes, cell-cycle control targets, and telomerase. Its ankyrin-repeat domain forms an extensive protein–protein interface with the GABPα ETS domain [PMID:9461436], while a C-terminal coiled-coil mediates β-subunit homodimerization and tetramerization [PMID:7958862]; transcriptional activation depends on tandem hydrophobic clusters within a conserved ~40-residue activation domain [PMID:8816484]. GABPB1 activates respiratory chain gene promoters through an HCF-1-bridged complex with the coactivator PRC [PMID:18343819], directly drives YAP transcription linking it to Hippo-pathway output [PMID:23684612], and—via its tetramer-forming long isoform GABPB1L—selectively activates the mutant TERT promoter in glioblastoma, where its disruption causes telomere shortening and tumor regression [PMID:30205050]. GABPB1 protein stability is regulated by BAIAP2L2-dependent protection from ubiquitin-mediated degradation and by antisense lncRNA GABPB1-AS1-mediated translational repression [PMID:39496939, PMID:31700067], and Gabpb1 knockout causes preimplantation lethality in mice [PMID:37640449]."},"prefetch_data":{"uniprot":{"accession":"Q06547","full_name":"GA-binding protein subunit beta-1","aliases":["GABP subunit beta-2","GABPB-2","Nuclear respiratory factor 2","Transcription factor E4TF1-47","Transcription factor E4TF1-53"],"length_aa":395,"mass_kda":42.5,"function":"Transcription factor capable of interacting with purine rich repeats (GA repeats) (PubMed:10675337, PubMed:8441384, PubMed:8816484). Acts as a master regulator of nuclear-encoded mitochondrial genes (By similarity) (Microbial infection) Necessary for the expression of the Adenovirus E4 gene","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q06547/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GABPB1","classification":"Not Classified","n_dependent_lines":606,"n_total_lines":1208,"dependency_fraction":0.5016556291390728},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GABPB1","total_profiled":1310},"omim":[{"mim_id":"621284","title":"GA-BINDING PROTEIN TRANSCRIPTION FACTOR, SUBUNIT BETA-2; GABPB2","url":"https://www.omim.org/entry/621284"},{"mim_id":"620845","title":"TRANSMEMBRANE 4 L6 FAMILY, MEMBER 19; TM4SF19","url":"https://www.omim.org/entry/620845"},{"mim_id":"600610","title":"GA-BINDING PROTEIN TRANSCRIPTION FACTOR, SUBUNIT BETA-1; GABPB1","url":"https://www.omim.org/entry/600610"},{"mim_id":"600609","title":"GA-BINDING PROTEIN TRANSCRIPTION FACTOR, ALPHA SUBUNIT; GABPA","url":"https://www.omim.org/entry/600609"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytoplasmic bodies","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GABPB1"},"hgnc":{"alias_symbol":["E4TF1-47","GABPB"],"prev_symbol":["GABPB2"]},"alphafold":{"accession":"Q06547","domains":[{"cath_id":"1.25.40.20","chopping":"2-164","consensus_level":"high","plddt":94.5498,"start":2,"end":164}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q06547","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q06547-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q06547-F1-predicted_aligned_error_v6.png","plddt_mean":68.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GABPB1","jax_strain_url":"https://www.jax.org/strain/search?query=GABPB1"},"sequence":{"accession":"Q06547","fasta_url":"https://rest.uniprot.org/uniprotkb/Q06547.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q06547/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q06547"}},"corpus_meta":[{"pmid":"31700067","id":"PMC_31700067","title":"LncRNA GABPB1-AS1 and GABPB1 regulate oxidative stress during erastin-induced ferroptosis in HepG2 hepatocellular carcinoma cells.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31700067","citation_count":194,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32844486","id":"PMC_32844486","title":"HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32844486","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35460557","id":"PMC_35460557","title":"Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma.","date":"2022","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35460557","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34276213","id":"PMC_34276213","title":"Long Non-Coding RNA GABPB1-AS1 Augments Malignancy of Glioma Cells by Sequestering MicroRNA-330 and Reinforcing the ZNF367/Cell Cycle Signaling Pathway.","date":"2021","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/34276213","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38081871","id":"PMC_38081871","title":"HOMER3 promotes non-small cell lung cancer growth and metastasis primarily through GABPB1-mediated mitochondrial metabolism.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38081871","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23486860","id":"PMC_23486860","title":"The GABPB1 gene A/G polymorphism in Polish rowers.","date":"2012","source":"Journal of human kinetics","url":"https://pubmed.ncbi.nlm.nih.gov/23486860","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35326537","id":"PMC_35326537","title":"Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35326537","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35342417","id":"PMC_35342417","title":"GABPB1-AS1 Promotes the Development of Osteosarcoma by Targeting SP1 and Activating the Wnt/β-Catenin Pathway.","date":"2022","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35342417","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37121382","id":"PMC_37121382","title":"LncRNA FTX Inhibits Ferroptosis of Hippocampal Neurons Displaying Epileptiform Discharges In vitro Through the miR-142-5p/GABPB1 Axis.","date":"2023","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37121382","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36756790","id":"PMC_36756790","title":"LncRNA GABPB1-IT1 inhibits the tumorigenesis of renal cancer via the miR-21/PTEN axis.","date":"2023","source":"Journal of biochemical and molecular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36756790","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37304650","id":"PMC_37304650","title":"GABPB1-AS1 acts as a tumor suppressor and inhibits non-small cell lung cancer progression by targeting miRNA-566/F-box protein 47.","date":"2022","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/37304650","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37640449","id":"PMC_37640449","title":"Incomplete activation of Alyref and Gabpb1 leads to preimplantation arrest in cloned mouse embryos.","date":"2023","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/37640449","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36997627","id":"PMC_36997627","title":"Hyperpolarized δ-[1- 13C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastoma.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36997627","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30904536","id":"PMC_30904536","title":"Association of SNP rs7181866 in the nuclear respiratory factor-2 beta subunit encoding GABPB1 gene with obesity and type-2 diabetes mellitus in South Indian population.","date":"2019","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30904536","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38466508","id":"PMC_38466508","title":"GABPB1 plays a cancer-promoting role in non-small cell lung cancer.","date":"2024","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38466508","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33346691","id":"PMC_33346691","title":"Association study of performance-related polymorphisms in Brazilian combat-sport athletes highlights variants in the GABPB1 gene.","date":"2020","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/33346691","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39496939","id":"PMC_39496939","title":"BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance.","date":"2024","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39496939","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39004908","id":"PMC_39004908","title":"LncRNA GABPB1-AS1 is a potential target for the diagnosis of prostate cancer.","date":"2024","source":"Nucleosides, nucleotides & nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/39004908","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39114718","id":"PMC_39114718","title":"Silencing lncRNA GABPB1-AS1 alleviates cerebral ischemia reperfusion injury through the miR-641/NUCKS1 axis.","date":"2024","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/39114718","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33664823","id":"PMC_33664823","title":"lncRNA GABPB1 intronic transcript 1 upregulates pigment epithelium-derived factor via miR-93 to suppress cell proliferation in hepatocellular carcinoma.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33664823","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40972828","id":"PMC_40972828","title":"Isoflurane aggravates cognitive deficits in aged rats via lncRNA GABPB1-AS1/miR-361-3p-mediated NLRP3 inflammasome activation.","date":"2025","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40972828","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35343317","id":"PMC_35343317","title":"Association of single nucleotide polymorphisms in the nuclear respiratory factor-2 beta subunit-encoding the GABPB1 gene within the occupational environment.","date":"2022","source":"Toxicology and industrial health","url":"https://pubmed.ncbi.nlm.nih.gov/35343317","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38824919","id":"PMC_38824919","title":"LncRNA GABPB1-IT1 Is Upregulated in Ischemia-Induced Acute Kidney Injury and Downregulates miR-204-5p to Promote Hypoxia-Induced Human Renal Proximal Tubular Epithelial Cell Apoptosis.","date":"2024","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/38824919","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40388723","id":"PMC_40388723","title":"Genetic biomarkers of skiers from the Oğlağo Tribe in Muş Province, Turkey: An analysis of ACTN3, VEGF-A, and GABPB1 polymorphisms.","date":"2025","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40388723","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16189514","id":"PMC_16189514","title":"Towards a proteome-scale map of the human protein-protein interaction network.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16189514","citation_count":2090,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19060904","id":"PMC_19060904","title":"An empirical framework for binary interactome mapping.","date":"2008","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/19060904","citation_count":652,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18976975","id":"PMC_18976975","title":"Genome-scale RNAi screen for host factors required for HIV replication.","date":"2008","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/18976975","citation_count":627,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16713569","id":"PMC_16713569","title":"A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16713569","citation_count":610,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9461436","id":"PMC_9461436","title":"The structure of GABPalpha/beta: an ETS domain- ankyrin repeat heterodimer bound to DNA.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9461436","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8383622","id":"PMC_8383622","title":"Identity of GABP with NRF-2, a multisubunit activator of cytochrome oxidase expression, reveals a cellular role for an ETS domain activator of viral promoters.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8383622","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21516116","id":"PMC_21516116","title":"Next-generation sequencing to generate interactome datasets.","date":"2011","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/21516116","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23684612","id":"PMC_23684612","title":"The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23684612","citation_count":112,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30205050","id":"PMC_30205050","title":"Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.","date":"2018","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/30205050","citation_count":107,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7799916","id":"PMC_7799916","title":"Four structurally distinct, non-DNA-binding subunits of human nuclear respiratory factor 2 share a conserved transcriptional activation domain.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7799916","citation_count":100,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32694731","id":"PMC_32694731","title":"Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.","date":"2020","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32694731","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8441384","id":"PMC_8441384","title":"cDNA cloning of transcription factor E4TF1 subunits with Ets and notch motifs.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8441384","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7958862","id":"PMC_7958862","title":"Molecular and genetic characterization of GABP beta.","date":"1994","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7958862","citation_count":73,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10675337","id":"PMC_10675337","title":"The novel coactivator C1 (HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10675337","citation_count":68,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18343819","id":"PMC_18343819","title":"PGC-1-related coactivator complexes with HCF-1 and NRF-2beta in mediating NRF-2(GABP)-dependent respiratory gene expression.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18343819","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8816484","id":"PMC_8816484","title":"Nuclear respiratory factors 1 and 2 utilize similar glutamine-containing clusters of hydrophobic residues to activate transcription.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8816484","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35831314","id":"PMC_35831314","title":"Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831314","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14154,"output_tokens":2688,"usd":0.041391},"stage2":{"model":"claude-opus-4-6","input_tokens":5996,"output_tokens":2432,"usd":0.13617},"total_usd":0.422665,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":26177,"output_tokens":4636,"usd":0.074036},"round2_rules_fired":"R2","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8434,"output_tokens":2875,"usd":0.171068}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2019,\n      \"finding\": \"The lncRNA GABPB1-AS1 downregulates GABPB1 protein levels by blocking GABPB1 mRNA translation (not by reducing mRNA levels), which in turn reduces expression of the PRDX5 peroxidase gene, suppressing cellular antioxidant capacity and promoting ferroptosis in HepG2 cells treated with erastin.\",\n      \"method\": \"Erastin treatment, Western blot for GABPB1 protein vs. mRNA levels, siRNA/overexpression of GABPB1-AS1, PRDX5 expression assays, cell viability readouts\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single lab, multiple orthogonal assays (protein vs. mRNA distinction, functional rescue), moderate evidence\",\n      \"pmids\": [\"31700067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GABPB1 positively regulates the expression of the PRDX5 peroxidase gene, thereby contributing to cellular antioxidant defense; loss of GABPB1 reduces PRDX5 and sensitizes cells to ferroptosis.\",\n      \"method\": \"GABPB1 knockdown/overexpression, PRDX5 mRNA and protein quantification, ferroptosis viability assays in HepG2 cells\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single lab with multiple assays linking GABPB1 to PRDX5 and oxidative stress outcome\",\n      \"pmids\": [\"31700067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GABPB1 is required for TERT expression and telomerase activation in thyroid carcinoma cells harboring mutant TERT promoter; GABPB1 knockdown diminishes TERT expression but paradoxically increases invasive and metastatic potential, and GABPB1 promoter hypermethylation silences its expression to promote TC aggressiveness.\",\n      \"method\": \"shRNA knockdown in TC cell lines, TERT mRNA/protein quantification, in vitro invasion assay, xenograft zebrafish metastasis model, methylation-specific PCR, DNA methylation inhibitor treatment\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KD, in vivo model, epigenetic analysis) in a single lab\",\n      \"pmids\": [\"35326537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Silencing GABPB1 in GBM models reduces TERT expression and modulates metabolic flux: GSH levels drop via reduced pentose phosphate pathway (PPP) flux and glucose-6-phosphate dehydrogenase activity/NADPH; lactate production falls via reduced glycolytic flux, GLUT1, monocarboxylate transporters, and lactate dehydrogenase A expression/activity.\",\n      \"method\": \"shRNA stable knockdown of GABPB1 in GBM cell lines and in vivo tumors, 1H-MRS and hyperpolarized 13C-MRS, enzymatic activity assays for G6PD, NADPH/NADH measurements, Western blot for metabolic enzymes\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal metabolic imaging and biochemical methods, in vitro and in vivo\",\n      \"pmids\": [\"35460557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GABPB1 silencing in GBM reduces flux through the pentose phosphate pathway, detectable by hyperpolarized [1-13C]gluconolactone MRS showing reduced 6-phosphogluconolactone production; TERT expression correlates positively with PPP flux, placing GABPB1 upstream of TERT in this metabolic axis.\",\n      \"method\": \"Stable shRNA knockdown of GABPB1, doxycycline-inducible shGABPB1, hyperpolarized 13C-MRS of live cells and in vivo tumors, 6PG quantification\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution-level metabolic flux imaging in multiple GBM models in vitro and in vivo, corroborated by prior study\",\n      \"pmids\": [\"36997627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HOMER3 and platelet-activating factor acetylhydrolase 1b catalytic subunit 3 (PAFAH1B3) cooperate to upregulate GABPB1 protein levels; GABPB1 acts downstream of HOMER3 as a key transcription factor for mitochondrial biogenesis controlling mitochondrial inner membrane genes, and loss of GABPB1 (via HOMER3 depletion) causes mitochondrial dysfunction suppressing NSCLC proliferation and invasion.\",\n      \"method\": \"Co-immunoprecipitation/interaction studies of HOMER3 with PAFAH1B3 and GABPB1, shRNA knockdown of HOMER3 with GABPB1 rescue, mitochondrial function assays (oxygen consumption, membrane potential), in vivo and in vitro proliferation/invasion assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — single lab, co-IP plus functional rescue, mitochondrial functional readouts\",\n      \"pmids\": [\"38081871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Gabpb1 is required for normal preimplantation mouse embryo development; CRISPR/Cas9 knockout of Gabpb1 causes early developmental arrest with increased apoptosis, and supplementation of Gabpb1 mRNA rescues preimplantation development of cloned (nuclear transfer) embryos whose Gabpb1 is silenced by H3K9me3-dependent repression.\",\n      \"method\": \"CRISPR/Cas9 knockout in mouse embryos, siRNA screening, mRNA microinjection rescue, H3K9me3 ChIP analysis, apoptosis assays in embryos\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO with clear phenotype, mRNA rescue, mechanistic link to H3K9me3 repression, multiple orthogonal methods\",\n      \"pmids\": [\"37640449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BAIAP2L2 interacts with GABPB1 protein to inhibit its ubiquitin-mediated proteasomal degradation and promote its nuclear translocation; this BAIAP2L2-GABPB1 interaction suppresses ROS levels and thereby promotes HCC malignant properties and lenvatinib resistance.\",\n      \"method\": \"Co-immunoprecipitation of BAIAP2L2 with GABPB1, ubiquitination assays, nuclear/cytoplasmic fractionation, ROS measurement, GABPB1 knockdown/overexpression in HCC cells, lenvatinib sensitivity assays\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — single lab, co-IP plus ubiquitination and fractionation assays linking interaction to functional outcome\",\n      \"pmids\": [\"39496939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GABPB1 knockdown in NSCLC cell lines (A549, H1299) decreases cell proliferation, colony formation, and increases apoptosis, establishing a tumor-promoting role for GABPB1 in lung cancer.\",\n      \"method\": \"shRNA-mediated knockdown of GABPB1, CCK-8 proliferation assay, colony formation assay, apoptosis assay\",\n      \"journal\": \"Discover oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single KD approach with phenotypic readouts but no pathway placement\",\n      \"pmids\": [\"38466508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In a hippocampal neuron epilepsy model, miR-142-5p directly targets and suppresses GABPB1, and lncRNA FTX acts as a ceRNA to sponge miR-142-5p, thereby de-repressing GABPB1 and inhibiting ferroptosis; this axis was validated by dual-luciferase assay and RNA immunoprecipitation.\",\n      \"method\": \"Dual-luciferase reporter assay, RNA immunoprecipitation (RIP), RT-qPCR, Western blot, CCK-8 and flow cytometry for ferroptosis/apoptosis in MGF-induced neurons\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, luciferase + RIP validates the targeting, functional rescue supports pathway placement\",\n      \"pmids\": [\"37121382\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABPB1 (GA-binding protein beta-1) is a transcription factor that drives expression of mitochondrial biogenesis genes and the antioxidant peroxidase PRDX5, is required for mutant TERT promoter-driven TERT expression and telomerase activation, modulates pentose phosphate pathway flux and glycolytic metabolism downstream of TERT in glioblastoma, is essential for preimplantation embryo survival (its loss causing apoptosis), is post-translationally stabilized and nuclear-translocalized by BAIAP2L2 (protecting it from ubiquitin-mediated degradation), and is regulated at the translational level by the antisense lncRNA GABPB1-AS1 and at the post-transcriptional level by miR-142-5p.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"GABPB1 (as part of NRF-2/GABP) was identified as a multi-subunit transcription factor whose beta subunit (GABPB1) forms heteromeric complexes with the DNA-binding alpha subunit and activates nuclear genes encoding mitochondrial respiratory chain components, including cytochrome c oxidase subunits IV and Vb. NRF-2 was shown to be identical to GABP, thus assigning a cellular role in respiratory gene expression to an ETS domain activator previously known only for viral promoter activation.\",\n      \"method\": \"Protein purification from HeLa cells, peptide sequencing, promoter binding assays, transfection assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical purification, peptide identity, functional promoter assays; foundational study replicated by subsequent work\",\n      \"pmids\": [\"8383622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"GABPB1 (E4TF1-53/E4TF1-47) was cloned and shown to contain four tandem ankyrin/notch repeats, lacks intrinsic DNA-binding activity, and heterodimerizes with the ETS-domain-containing alpha subunit (E4TF1-60/GABPα) to form a functional transcription factor complex; heterodimerization is essential for transcriptional activity.\",\n      \"method\": \"Protein purification, partial amino acid sequencing, cDNA cloning, gel retardation assay, recombinant protein expression in E. coli\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with purified recombinant proteins, functional gel-shift validation\",\n      \"pmids\": [\"8441384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Four structurally distinct beta/gamma subunits of NRF-2 (including GABPB1/beta1 and beta2, and gamma1/gamma2 variants with a 12-amino-acid insertion) were cloned and shown to share a conserved ~70 amino acid transcriptional activation domain containing tandem glutamine-containing hydrophobic clusters. All four subunits associate with GABPα and support high-affinity binding to tandem NRF-2 sites, and all activate transcription equally when fused to a GAL4 DNA-binding domain.\",\n      \"method\": \"cDNA cloning, overexpression, co-immunoprecipitation, GAL4 fusion transcription assays, deletion mapping, PCR, RNase protection\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods in single study defining activation domain and subunit interactions\",\n      \"pmids\": [\"7799916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The mouse genome encodes two highly related GABP beta polypeptides (GABPβ1 and GABPβ2) whose carboxy-terminal regions mediate dimerization via a coiled-coil (leucine zipper-like) mechanism. GABPβ1 and GABPβ2 can heterodimerize through this domain. The three GABP subunit genes map to three unlinked chromosomal loci yet show concordant expression patterns.\",\n      \"method\": \"Genomic and cDNA cloning, circular dichroism spectroscopy of synthetic peptides, leucine zipper swap experiment, chromosomal mapping\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural demonstration of coiled-coil dimerization by CD and functional leucine zipper replacement assay\",\n      \"pmids\": [\"7958862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The transcriptional activation domain of NRF-2 (GABPB1) was mapped by deletion and alanine substitution mutagenesis to tandemly arranged clusters of hydrophobic amino acids (containing glutamines) within a ~40 residue region. Glutamine residues themselves are not required for activation; rather, the surrounding hydrophobic residues are essential. This mechanism is shared with NRF-1.\",\n      \"method\": \"Deletion mutagenesis, alanine substitution mutagenesis, transfection-based transcription assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis defining essential residues for activation domain function\",\n      \"pmids\": [\"8816484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The crystal structure of GABPα/β (ETS domain – ankyrin repeat heterodimer) bound to DNA was determined at 2.15 Å resolution. The structure reveals: (1) the ankyrin repeats of GABPβ form an extensive protein-protein interface with both the ETS domain and a C-terminal extension of GABPα; (2) GABPα binds DNA through the GGA core recognition motif; (3) GABPβ is recruited by GABPα using both the ETS domain and a C-terminal extension of GABPα.\",\n      \"method\": \"X-ray crystallography at 2.15 Å resolution\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with functional context; landmark structural study\",\n      \"pmids\": [\"9461436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The cellular coactivator C1/HCF directly interacts with GABPβ (GABPB1), functioning as a novel coactivator of GABP-mediated transcription. Mutations in GABPβ that reduce GABP transactivation potential also impair the C1-GABP interaction, indicating C1/HCF mediates GABP transcriptional activity. C1/HCF coordinates multi-protein enhancer assembly at HSV-1 IE gene promoters by interacting with GABP, Oct-1, and αTIF.\",\n      \"method\": \"Co-immunoprecipitation, mutagenesis, transcription assays, HSV-1 IE gene enhancer functional studies\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction demonstrated with mutagenesis linking binding to function\",\n      \"pmids\": [\"10675337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PRC (PGC-1-related coactivator) associates with NRF-2/GABP in vivo via an HCF-1 intermediary. Neither PRC nor PGC-1α binds NRF-2β (GABPB1) directly; instead HCF-1 bridges the complex. Both PRC and NRF-2β bind HCF-1 in vitro. The PRC–HCF-1–NRF-2 complex occupies NRF-2-dependent promoters (TFB1M, TFB2M) in vivo, and PRC knockdown reduces TFB2M mRNA and mitochondrial transcripts and cytochrome oxidase activity.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assays, chromatin immunoprecipitation, shRNA knockdown, enzyme activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Co-IP, ChIP, in vitro binding, functional KD) defining bridged complex\",\n      \"pmids\": [\"18343819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GABP (requiring GABPB1 as a functional partner) directly binds the YAP/Yap promoter and activates YAP transcription. Depletion of GABP downregulates YAP, causing G1/S cell-cycle arrest and increased cell death, both rescued by YAP reconstitution. GABP transcriptional activity is inhibited by oxidative stress (glutathione depletion), linking GABP to the Hippo pathway as an upstream activator of YAP.\",\n      \"method\": \"ChIP, shRNA knockdown, YAP reconstitution rescue, cell cycle analysis, promoter reporter assay, in vivo mouse liver injury model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct promoter binding, genetic epistasis via YAP reconstitution rescue, multiple orthogonal methods\",\n      \"pmids\": [\"23684612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GABPB1L (the long isoform of GABPB1, β1L), which enables GABP tetramer formation, is selectively required for activating the mutant TERT promoter in glioblastoma cells harboring TERT promoter mutations. Genetic disruption of β1L silences TERT expression in a TERT promoter mutation-dependent manner, leading to telomere shortening and cell death exclusively in mutant cells, with no effect on normal cells. In vivo, β1L disruption reduces tumor burden and extends survival in orthotopic xenograft models.\",\n      \"method\": \"CRISPR-mediated gene disruption, shRNA knockdown, TERT expression analysis, telomere length assays, orthotopic xenograft in vivo model\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO with isoform-specific rescue, in vivo validation, mutation-selective phenotype demonstrated across multiple models\",\n      \"pmids\": [\"30205050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GABPB1 knockdown in thyroid cancer cells harboring TERT promoter mutations diminishes TERT expression and telomerase activity but paradoxically increases invasive potential in vitro and metastatic potential in a zebrafish xenograft model, with altered EMT marker expression. GABPB1 promoter hypermethylation suppresses its expression in aggressive thyroid cancers, and DNA methylation inhibitors restore GABPB1 expression. This demonstrates that GABPB1 has dual roles: required for TERT/telomerase activation but also functioning as a tumor suppressor to limit thyroid cancer progression.\",\n      \"method\": \"shRNA knockdown, invasion assays, zebrafish xenograft model, methylation-specific PCR, DNA methylation inhibitor treatment, EMT marker analysis\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vitro and in vivo methods but single lab; paradoxical tumor suppressor finding adds complexity\",\n      \"pmids\": [\"35326537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GABPB1 silencing in TERT-promoter-mutant GBM cells reduces lactate, glutathione (GSH), and hyperpolarized [1-13C]lactate production as detected by 1H- and 13C-MRS. Mechanistically, GSH reduction is linked to reduced pentose phosphate pathway flux and glucose-6-phosphate dehydrogenase activity, and lactate reduction is associated with decreased glycolytic flux, NADH, and reduced expression/activity of GLUT1, monocarboxylate transporters, and lactate dehydrogenase A.\",\n      \"method\": \"1H-MRS, hyperpolarized 13C-MRS, enzyme activity assays, shRNA knockdown, in vivo tumor models\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple metabolic readouts in vitro and in vivo, single lab\",\n      \"pmids\": [\"35460557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HOMER3 and platelet-activating factor acetylhydrolase 1b catalytic subunit 3 cooperate to upregulate GABPB1 protein levels in NSCLC, which in turn controls mitochondrial inner membrane gene expression and mitochondrial function. Loss of HOMER3 reduces GABPB1 levels, leading to mitochondrial dysfunction and decreased proliferation and invasion of lung cancer cells in vitro and in vivo.\",\n      \"method\": \"shRNA knockdown, co-immunoprecipitation, in vitro and in vivo proliferation/invasion assays, mitochondrial function assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — upstream regulation of GABPB1 established by KD and Co-IP; single lab\",\n      \"pmids\": [\"38081871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GABPB1 was identified as a developmentally essential gene in mice; CRISPR/Cas9 knockout of Gabpb1 results in early preimplantation developmental arrest associated with apoptosis. In nuclear transfer (cloned) embryos, Gabpb1 fails to be properly reactivated due to H3K9me3-mediated repression (partly through repressed Klf16 expression), and supplementation of Gabpb1 mRNA supports efficient preimplantation development of cloned embryos.\",\n      \"method\": \"CRISPR/Cas9 knockout, siRNA screening, mRNA supplementation rescue, H3K9me3 ChIP analysis, embryo development assays\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO lethal phenotype with mRNA rescue, epigenetic mechanism identified; single lab\",\n      \"pmids\": [\"37640449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Erastin upregulates the lncRNA GABPB1-AS1, which blocks translation of GABPB1 protein (without altering mRNA levels), leading to reduced PRDX5 (Peroxiredoxin-5) expression, suppressed antioxidant capacity, and ferroptotic cell death in HepG2 hepatocellular carcinoma cells. GABPB1 protein thus functions downstream of GABPB1-AS1 to maintain PRDX5 expression and cellular redox homeostasis.\",\n      \"method\": \"Erastin treatment, lncRNA overexpression/knockdown, Western blot (protein level without mRNA change), PRDX5 reporter assay, cell viability assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — translational repression mechanism with functional link to PRDX5 and ferroptosis; single lab\",\n      \"pmids\": [\"31700067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BAIAP2L2 interacts with GABPB1 protein to inhibit its ubiquitin-mediated degradation and promote its nuclear translocation in hepatocellular carcinoma cells. NFκB1 stimulates BAIAP2L2 transcription by binding its promoter. Through stabilizing GABPB1 and promoting its nuclear entry, BAIAP2L2 reduces ROS levels and enhances HCC malignancy and lenvatinib resistance.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, nuclear/cytoplasmic fractionation, promoter binding ChIP assay, shRNA knockdown, ROS measurement\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP demonstrates interaction, ubiquitination assay shows degradation mechanism, fractionation shows localization; single lab\",\n      \"pmids\": [\"39496939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"shRNA-mediated suppression of GABPB1 in NSCLC cell lines A549 and H1299 decreases cell growth, clone formation, and increases apoptosis rate, confirming a cancer-promoting role for GABPB1 in lung cancer cell proliferation and survival.\",\n      \"method\": \"shRNA knockdown, colony formation assay, CCK-8 cell viability, apoptosis assay\",\n      \"journal\": \"Discover oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, KD phenotype without detailed pathway placement\",\n      \"pmids\": [\"38466508\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABPB1 encodes the beta subunit(s) of the heteromeric ETS transcription factor GABP/NRF-2; it contains ankyrin repeats that mediate direct protein-protein contact with the DNA-binding GABPα subunit (as revealed by crystal structure), a C-terminal coiled-coil domain enabling GABPβ homodimerization and tetramerization, and a conserved hydrophobic activation domain; the tetramer-forming long isoform GABPβ1L selectively activates mutant TERT promoters in cancer cells, while GABPB1 broadly activates nuclear-encoded mitochondrial respiratory and biogenesis genes through complexes that include HCF-1 and PRC coactivators, regulates YAP transcription as part of the Hippo pathway, is itself regulated post-translationally by BAIAP2L2-dependent protection from ubiquitin-mediated degradation, and is required for preimplantation mouse development where its loss causes apoptosis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GABPB1 is a transcription factor subunit that integrates transcriptional control of antioxidant defense, mitochondrial biogenesis, and telomerase activation. GABPB1 directly drives expression of the peroxidase PRDX5 to maintain cellular antioxidant capacity, and its loss sensitizes cells to ferroptosis [PMID:31700067]; it also transactivates mitochondrial inner membrane genes downstream of a HOMER3–PAFAH1B3 signaling axis, and its depletion causes mitochondrial dysfunction [PMID:38081871]. In cancers harboring mutant TERT promoters, GABPB1 is required for TERT expression and consequent metabolic reprogramming, including pentose phosphate pathway flux and glycolytic output [PMID:35460557, PMID:36997627]. Gabpb1 is essential for preimplantation embryo survival, as CRISPR knockout causes developmental arrest with apoptosis that is rescued by Gabpb1 mRNA supplementation [PMID:37640449].\",\n  \"teleology\": [\n    {\n      \"year\": 2019,\n      \"claim\": \"Establishing that GABPB1 is a transcriptional activator of the peroxidase PRDX5 and that its suppression—specifically at the translational level by the antisense lncRNA GABPB1-AS1—reduces antioxidant defense and promotes ferroptosis, providing the first functional link between GABPB1 and redox homeostasis.\",\n      \"evidence\": \"GABPB1-AS1 overexpression/knockdown with Western blot versus mRNA quantification, PRDX5 expression and cell viability assays in erastin-treated HepG2 cells\",\n      \"pmids\": [\"31700067\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct binding of GABPB1 to the PRDX5 promoter was not shown by ChIP\",\n        \"Translational block mechanism by the antisense lncRNA was not structurally resolved\",\n        \"Generalizability beyond HepG2/erastin context not tested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating that GABPB1 is required for mutant TERT promoter-driven TERT expression and that this transcriptional relationship extends to downstream metabolic consequences—reduced pentose phosphate pathway flux, NADPH, GSH, and glycolytic output—thereby linking GABPB1 to cancer metabolic reprogramming.\",\n      \"evidence\": \"shRNA knockdown in GBM and thyroid carcinoma lines, hyperpolarized 13C-MRS metabolic flux imaging in vitro and in vivo, enzymatic activity assays, xenograft models\",\n      \"pmids\": [\"35326537\", \"35460557\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether GABPB1 directly binds the mutant TERT promoter ETS motifs or requires GABPA heterodimerization was not dissected\",\n        \"Metabolic effects attributable to TERT loss versus other GABPB1 targets were not separated\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Confirming the GABPB1–PPP metabolic axis with an independent imaging modality (hyperpolarized [1-13C]gluconolactone) and extending it to in vivo GBM tumors, solidifying GABPB1 as an upstream determinant of PPP flux through TERT.\",\n      \"evidence\": \"Doxycycline-inducible shGABPB1, hyperpolarized 13C-MRS of 6-phosphogluconolactone in live cells and xenografts\",\n      \"pmids\": [\"36997627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No direct demonstration that TERT enzymatic activity (vs. TERT protein level) is required for PPP modulation\",\n        \"Mechanism by which TERT protein controls G6PD activity unresolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealing that GABPB1 functions as a key transcription factor for mitochondrial biogenesis genes and is regulated upstream by a HOMER3–PAFAH1B3 protein complex that stabilizes GABPB1 protein levels, establishing a signaling-to-transcription axis controlling mitochondrial function.\",\n      \"evidence\": \"Co-immunoprecipitation of HOMER3/PAFAH1B3/GABPB1, shRNA knockdown with GABPB1 rescue, oxygen consumption and membrane potential assays in NSCLC cells\",\n      \"pmids\": [\"38081871\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which HOMER3–PAFAH1B3 stabilizes GABPB1 (e.g., blocking specific E3 ligase) not identified\",\n        \"Single Co-IP study; reciprocal endogenous validation limited\",\n        \"Specific mitochondrial gene targets of GABPB1 not mapped genome-wide\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrating that Gabpb1 is essential for preimplantation embryo development—its knockout causes arrest and apoptosis—and that H3K9me3-mediated silencing of Gabpb1 is a barrier in somatic cell nuclear transfer embryos that can be overcome by mRNA supplementation.\",\n      \"evidence\": \"CRISPR/Cas9 knockout in mouse embryos, mRNA injection rescue of SCNT embryos, H3K9me3 ChIP, apoptosis assays\",\n      \"pmids\": [\"37640449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Downstream target genes essential for preimplantation survival not identified\",\n        \"Whether Gabpb1 acts via mitochondrial biogenesis or antioxidant function in embryos is unknown\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identifying miR-142-5p as a direct post-transcriptional repressor of GABPB1 in hippocampal neurons, with the lncRNA FTX acting as a competing endogenous RNA to de-repress GABPB1 and suppress ferroptosis, broadening GABPB1 regulation to the neuronal context.\",\n      \"evidence\": \"Dual-luciferase reporter and RNA immunoprecipitation for miR-142-5p–GABPB1 interaction, ferroptosis assays in Mg²⁺-free-induced epileptic neurons\",\n      \"pmids\": [\"37121382\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"In vivo relevance in epilepsy models not demonstrated\",\n        \"Whether GABPB1's anti-ferroptotic role here also proceeds via PRDX5 not tested\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showing that BAIAP2L2 physically interacts with GABPB1, shields it from ubiquitin-dependent proteasomal degradation, and promotes its nuclear translocation, thereby suppressing ROS and conferring lenvatinib resistance in hepatocellular carcinoma.\",\n      \"evidence\": \"Co-immunoprecipitation, ubiquitination assays, nuclear/cytoplasmic fractionation, ROS measurement, drug sensitivity assays in HCC cells\",\n      \"pmids\": [\"39496939\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The E3 ubiquitin ligase targeting GABPB1 for degradation was not identified\",\n        \"Structural basis of BAIAP2L2–GABPB1 interaction unknown\",\n        \"Single-lab study without independent replication\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The E3 ligase(s) mediating GABPB1 ubiquitination and turnover, the genome-wide direct transcriptional targets of GABPB1 in different cellular contexts, and the structural basis of GABPA–GABPB1 heterodimerization-dependent versus independent functions remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No genome-wide ChIP-seq for GABPB1 binding sites across cell types reported in the timeline\",\n        \"E3 ligase identity unknown\",\n        \"Whether GABPB1 functions independently of GABPA in any context is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 5]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6, 8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"BAIAP2L2\",\n      \"HOMER3\",\n      \"PAFAH1B3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"GABPB1 encodes the transcriptional activation subunit of the heteromeric ETS-family transcription factor GA-binding protein (GABP/NRF-2), functioning as an obligate partner of the DNA-binding GABPα subunit to regulate nuclear-encoded mitochondrial genes, cell-cycle control targets, and telomerase. Its ankyrin-repeat domain forms an extensive protein–protein interface with the GABPα ETS domain [PMID:9461436], while a C-terminal coiled-coil mediates β-subunit homodimerization and tetramerization [PMID:7958862]; transcriptional activation depends on tandem hydrophobic clusters within a conserved ~40-residue activation domain [PMID:8816484]. GABPB1 activates respiratory chain gene promoters through an HCF-1-bridged complex with the coactivator PRC [PMID:18343819], directly drives YAP transcription linking it to Hippo-pathway output [PMID:23684612], and—via its tetramer-forming long isoform GABPB1L—selectively activates the mutant TERT promoter in glioblastoma, where its disruption causes telomere shortening and tumor regression [PMID:30205050]. GABPB1 protein stability is regulated by BAIAP2L2-dependent protection from ubiquitin-mediated degradation and by antisense lncRNA GABPB1-AS1-mediated translational repression [PMID:39496939, PMID:31700067], and Gabpb1 knockout causes preimplantation lethality in mice [PMID:37640449].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Identification of GABPB1 as the non-DNA-binding subunit of GABP/NRF-2 resolved how an ETS-family factor activates nuclear-encoded mitochondrial respiratory genes, establishing the obligate α/β heterodimer architecture.\",\n      \"evidence\": \"Protein purification from HeLa cells with peptide sequencing, promoter binding and transfection assays; independent cDNA cloning showing ankyrin repeats and heterodimerization requirement\",\n      \"pmids\": [\"8383622\", \"8441384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural detail on how ankyrin repeats contact GABPα\", \"Activation domain not yet mapped\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Characterization of multiple GABPB splice isoforms and mapping of a conserved hydrophobic activation domain defined the modular architecture through which GABPB1 transduces transcriptional activation, while identification of the coiled-coil dimerization motif explained how β subunits oligomerize.\",\n      \"evidence\": \"cDNA cloning, GAL4 fusion assays, deletion/alanine mutagenesis, circular dichroism spectroscopy of coiled-coil peptides\",\n      \"pmids\": [\"7799916\", \"7958862\", \"8816484\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the coiled-coil tetramer\", \"Functional distinction between β1 and β2 isoforms unclear\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"The 2.15 Å crystal structure of the GABPα ETS domain–GABPβ ankyrin repeat complex on DNA revealed the molecular basis for obligate heterodimerization and indirect DNA recognition by the β subunit.\",\n      \"evidence\": \"X-ray crystallography at 2.15 Å resolution\",\n      \"pmids\": [\"9461436\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure lacks the activation domain and coiled-coil tetramerization region\", \"No structure of the full-length tetramer on tandem ETS sites\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery that HCF-1 (C1) directly binds GABPB1 and functions as a coactivator established the first known coactivator partnership for GABP, later shown to bridge additional coactivators such as PRC to NRF-2-dependent promoters.\",\n      \"evidence\": \"Co-immunoprecipitation, mutagenesis linking interaction to transactivation, in vitro binding, ChIP, shRNA knockdown of PRC\",\n      \"pmids\": [\"10675337\", \"18343819\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the PRC–HCF-1–GABP complex on chromatin unknown\", \"Whether other coactivators use the same HCF-1 bridge is untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstration that GABP directly binds and activates the YAP promoter linked GABPB1 to Hippo pathway regulation and cell-cycle control, broadening its role beyond mitochondrial biogenesis.\",\n      \"evidence\": \"ChIP, shRNA knockdown, YAP reconstitution rescue, cell-cycle analysis, in vivo mouse liver injury model\",\n      \"pmids\": [\"23684612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GABP regulation of YAP is tissue-specific is unexplored\", \"Mechanism by which oxidative stress inhibits GABP DNA-binding activity not fully resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The finding that the tetramer-forming long isoform GABPB1L is selectively required for mutant TERT promoter activation in glioblastoma provided an isoform-specific oncogenic mechanism and a potential therapeutic vulnerability.\",\n      \"evidence\": \"CRISPR disruption of GABPB1L, isoform-specific rescue, telomere length assays, orthotopic xenograft models\",\n      \"pmids\": [\"30205050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GABPB1L selectivity for mutant TERT extends to all TERT-promoter-mutant cancer types is incompletely tested\", \"Structural basis for why the tetramer, but not the dimer, activates the mutant promoter is unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of lncRNA GABPB1-AS1 as a translational repressor of GABPB1 revealed a post-transcriptional regulatory layer linking GABPB1 levels to antioxidant defense (PRDX5 expression) and ferroptosis susceptibility.\",\n      \"evidence\": \"Erastin treatment, antisense lncRNA overexpression/knockdown, Western blot showing protein but not mRNA change, PRDX5 reporter assay in HepG2 cells\",\n      \"pmids\": [\"31700067\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Translational repression mechanism (ribosome stalling vs. mRNA sequestration) is undefined\", \"Generalizability beyond HepG2 cells not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Studies in thyroid cancer and GBM revealed that GABPB1 silencing not only reduces TERT expression but also reshapes glycolytic/redox metabolism and paradoxically enhances invasion in certain contexts, revealing context-dependent roles.\",\n      \"evidence\": \"shRNA knockdown, 1H/13C-MRS metabolomics, invasion assays, zebrafish xenograft, methylation-specific PCR\",\n      \"pmids\": [\"35326537\", \"35460557\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether metabolic changes are direct transcriptional targets or secondary to TERT loss is unresolved\", \"Paradoxical tumor-suppressive effect in thyroid cancer awaits independent replication\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Gabpb1 knockout causes preimplantation embryonic lethality with apoptosis in mice, and mRNA supplementation rescues cloned embryo development, establishing GABPB1 as essential for early mammalian development.\",\n      \"evidence\": \"CRISPR/Cas9 knockout, mRNA rescue, H3K9me3 ChIP in nuclear transfer embryos\",\n      \"pmids\": [\"37640449\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific GABPB1 target genes required for preimplantation survival are not identified\", \"Whether the essential role maps to mitochondrial gene regulation or another program is unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"BAIAP2L2 was shown to stabilize GABPB1 by blocking ubiquitin-mediated degradation and promoting nuclear translocation, identifying the first post-translational stabilization pathway for GABPB1 and linking it to drug resistance in HCC.\",\n      \"evidence\": \"Co-immunoprecipitation, ubiquitination assay, nuclear/cytoplasmic fractionation, ChIP for NFκB1 binding to BAIAP2L2 promoter\",\n      \"pmids\": [\"39496939\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The E3 ubiquitin ligase targeting GABPB1 for degradation is unidentified\", \"Whether BAIAP2L2-mediated stabilization operates outside HCC is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include the structural basis for GABPB1L tetramer selectivity at mutant TERT promoters, the identity of the E3 ligase governing GABPB1 turnover, and the full set of direct transcriptional targets that account for GABPB1's essential developmental role.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length tetramer structure exists\", \"E3 ligase for GABPB1 ubiquitination unknown\", \"Genome-wide direct target catalog in developmental context is lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 4, 8, 9]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 5, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 8, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 4, 8, 9]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 7, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 10, 11]}\n    ],\n    \"complexes\": [\n      \"GABP (NRF-2) heterodimer/tetramer\",\n      \"PRC–HCF-1–NRF-2 coactivator complex\"\n    ],\n    \"partners\": [\n      \"GABPA\",\n      \"HCF1\",\n      \"PPRC1\",\n      \"BAIAP2L2\",\n      \"HOMER3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}